294 related articles for article (PubMed ID: 37165498)
1. An Up-to-date Review on Protein-based Nanocarriers in the Management of Cancer.
Almalki WH
Curr Drug Deliv; 2024; 21(4):509-524. PubMed ID: 37165498
[TBL] [Abstract][Full Text] [Related]
2. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Cancer chemotherapy with lipid-based nanocarriers.
Liu D; Zhang N
Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers for Anticancer Drug Targeting: Recent Trends and Challenges.
Dahiya S; Dahiya R; Hernández E
Crit Rev Ther Drug Carrier Syst; 2021; 38(6):49-103. PubMed ID: 34587429
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
[TBL] [Abstract][Full Text] [Related]
9. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
10. Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy.
Nogueira-Librelotto DR; Codevilla CF; Farooqi A; Rolim CM
Curr Pharm Des; 2017; 23(3):454-466. PubMed ID: 27784246
[TBL] [Abstract][Full Text] [Related]
11. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.
Din FU; Aman W; Ullah I; Qureshi OS; Mustapha O; Shafique S; Zeb A
Int J Nanomedicine; 2017; 12():7291-7309. PubMed ID: 29042776
[TBL] [Abstract][Full Text] [Related]
12. Multi-functional nanocarriers to overcome tumor drug resistance.
Jabr-Milane LS; van Vlerken LE; Yadav S; Amiji MM
Cancer Treat Rev; 2008 Nov; 34(7):592-602. PubMed ID: 18538481
[TBL] [Abstract][Full Text] [Related]
13. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate derived theranostic and therapeutic nanocarriers for tumor-targeted drug delivery.
Khan AR; Yang X; Du X; Yang H; Liu Y; Khan AQ; Zhai G
Carbohydr Polym; 2020 Apr; 233():115837. PubMed ID: 32059890
[TBL] [Abstract][Full Text] [Related]
15. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
Aljuffali IA; Fang CL; Chen CH; Fang JY
Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
[TBL] [Abstract][Full Text] [Related]
18. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.
Phillips MC; Mousa SA
Nanomedicine (Lond); 2022 Mar; 17(6):405-421. PubMed ID: 35118878
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
